Respiratory, thoracic, and mediastinal adverse events associated with ticagrelor: A pharmacovigilance study based on FDA adverse event reporting system

Related articles

1. Vedolizumab adverse event profile: pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)

   This article has 4 authors:

   1. Guanghui Yuan
   2. Jie Liu
   3. Yi Xu
   4. Zhaowei Shan

2. Major Adverse Cardiovascular Events in Patients Treated With Anthracyclines for Breast Cancer or Lymphoma: 25-Year Follow-Up

   This article has 10 authors:

   1. Eduardo Tellez-Garcia
   2. Andres E. Daryanani Acevedo
   3. Maria F. Gomez Ardila
   4. Carolina Ricaurte
   5. Carolyn M. Larsen
   6. Joerg Herrmann
   7. Tufia C. Haddad
   8. Carrie A. Thompson
   9. James R. Cerhan
   10. Hector R. Villarraga

3. Drug-induced atrial fibrillation: A real-world pharmacovigilance study using the US Food and Drug Administration Adverse Event Reporting System database

   This article has 6 authors:

   1. Jingsi Fu
   2. Yixue Wu
   3. Zheyu Guo
   4. Jian Wu
   5. Xin Su
   6. Jiaxing Li